/5
0 avis
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
Archive ouverte
International audience
Consulter en ligne
Chargement des enrichissements...